Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA3H7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,343
Award facts
- Contract value 100% obligated
- $13,342.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,342.86 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract, awarded on January 22, 2026, with an ultimate completion date of January 23, 2026, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be conducted at the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 31, 2031, serving as the vehicle for comprehensive pharmaceutical supply to military healthcare systems globally.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a diverse range of pharmaceutical products across multiple therapeutic domains, including diabetes medications, specialty treatments, vaccines, and medical supplies. This specific delivery order for Ozempic reflects the ongoing demand for diabetes management medications within the Defense Health Agency and other military healthcare programs. The firm fixed-price structure and rapid completion timeline indicate routine replenishment of this essential medication to support operational readiness across military treatment facilities and related federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FA3H7?
SPE2DR26FA3H7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FA3H7 worth?
The government has obligated $13,343 on SPE2DR26FA3H7.
Is contract SPE2DR26FA3H7 an order under another contract?
Yes. SPE2DR26FA3H7 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA3H7 competed?
The extent of competition for SPE2DR26FA3H7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award